Brief introduction of Jiangsu Wang Ao Pharmaceutical Co., Ltd.

The main dosage forms are soft capsules, dripping pills, capsules, granules and tablets. The whole factory has passed the national GMP certification in 2005, and has formed a certain industrial base and large production conditions in the process of continuous development. Employees 136, including 4 masters, 32 undergraduates and 36 junior college students, with employees above junior college accounting for 52% of the total employees. The proportion of scientific and technical personnel engaged in research and development reached 18%. Haimen is one of the pharmaceutical enterprises with the fastest development, the best benefit and the strongest scientific and technological strength in recent years, and it is also a national high-tech enterprise. The company has many honors. In 2006, it was awarded as a demonstration enterprise in Nantong Industry-University-Research, a high-tech enterprise in Jiangsu Province and an intellectual property demonstration and cultivation enterprise in Haimen City in 2007, and a national high-tech enterprise in June 2009. 20 10 won the bronze medal in Haimen city. After years of business exploration, the company has accumulated rich experience in product research and development, enterprise management and marketing, established the business strategy of "making fine medical products and specialized markets", has been focusing on the research and development of high-tech products, and has set the establishment of pharmaceutical production bases in high-tech fields supported by the state as its strategic goal. At present, the company has 17 varieties rated as high-tech products in Jiangsu province, 6 varieties rated as independent innovation products in Jiangsu province, and has 13 invention patents, and more than 20 patent applications are being accepted. Since the company was founded seven years ago, * * * has completed more than 70 R&D projects, including 25 scientific research projects transformed into workshop mass production, and successfully transformed projects 18 in the past three years. Most of the projects operated by the company belong to the high-tech fields supported by the state. Most of the projects belong to the category of traditional Chinese medicine, natural products and chemical substances in new biological and medical technologies, including the development of new varieties of traditional Chinese medicine, drugs for treating cardiovascular and cerebrovascular diseases, drugs for mental nervous system, anti-infective drugs and so on. The company has carried out extensive R&D cooperation and exchanges with many universities and scientific research institutions, and cooperated with nearly ten universities and scientific research institutions, such as China Pharmaceutical University, Anhui College of Traditional Chinese Medicine and Anhui Institute of Medicine, to complete the experimental development and research on bioequivalence of many varieties of human beings. In addition, 10%- 15% of the company's annual research funding is the external driving force for the continuous development and growth of the company's scientific research capabilities. The company attaches great importance to brand building, always adheres to the business philosophy of quality first and technology as the core competitiveness, takes the continuous improvement of product quality, R&D level and strengthening market service as the company's business principles, makes unremitting efforts, and sincerely interprets the corporate purpose of "honesty, good medicine and benefiting mankind" in business practice. "Sincerity, care and innovation" Wan Gaoren is willing to cooperate sincerely with all medical colleagues who are committed to the cause of national health and work together for human health.